Abstract
In this work, it is described a novel micro-nanoplatform for pulmonary administration of active ingredients (AIs), including chitosan (CS)-based nanocapsules (NCs) with/without hyaluronic acid (HA), to treat lung diseases. Specifically, CS NCs and HA/CS NCs were microencapsulated in mannitol microspheres (Ma MS) by a simple spray-drying technique that gave as result dry powders of suitable characteristics for inhalation. Ma MS showed spherical morphology and sizes between 1 and 5 μm, with homogeneous distribution of NCs inside them. In aqueous media, the powders released rapidly the NCs, maintaining approximately their physicochemical characteristics. In vitro studies in A549 cells showed high cell viabilities after contact with both NCs (>90%) and Ma (≥99%); being, approximately, a 100% of cells internalized with NCs. For first time, it is exhaustively described the adjustment of the spray-drying process of NCs, resulting in a suitable and safe micro-nanoplatform of great potential for pulmonary administration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.